Steven R. Ripa

544 total citations
22 papers, 441 citations indexed

About

Steven R. Ripa is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Steven R. Ripa has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Physiology and 12 papers in Anesthesiology and Pain Medicine. Recurrent topics in Steven R. Ripa's work include Opioid Use Disorder Treatment (15 papers), Pain Mechanisms and Treatments (13 papers) and Pain Management and Opioid Use (12 papers). Steven R. Ripa is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Pain Mechanisms and Treatments (13 papers) and Pain Management and Opioid Use (12 papers). Steven R. Ripa collaborates with scholars based in United States and Canada. Steven R. Ripa's co-authors include Warren Wen, Catherine Munera, Craig Landau, Robert B. Raffa, K. Miller, M. Hale, Deborah Steiner, Aaron Yarlas, Deborah J. Steiner and Ellie He and has published in prestigious journals such as Archives of Physical Medicine and Rehabilitation, Journal of Pain and Symptom Management and Journal of Pain.

In The Last Decade

Steven R. Ripa

21 papers receiving 412 citations

Peers

Steven R. Ripa
Brigitte Kuperwasser United States
Thomas Häufel United States
Robert J. Rose United States
Ilona Steigerwald Germany
Craig Landau United States
Andreas Wehrfritz Germany
James Wild United States
Theresa Mallick‐Searle United States
Matthias Müller Germany
Kristin Moksnes Norway
Brigitte Kuperwasser United States
Steven R. Ripa
Citations per year, relative to Steven R. Ripa Steven R. Ripa (= 1×) peers Brigitte Kuperwasser

Countries citing papers authored by Steven R. Ripa

Since Specialization
Citations

This map shows the geographic impact of Steven R. Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Ripa more than expected).

Fields of papers citing papers by Steven R. Ripa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Ripa. The network helps show where Steven R. Ripa may publish in the future.

Co-authorship network of co-authors of Steven R. Ripa

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Ripa. A scholar is included among the top collaborators of Steven R. Ripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Ripa. Steven R. Ripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silverman, Sanford M., et al.. (2017). Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system. Journal of Pain Research. Volume 10. 1255–1263. 8 indexed citations
2.
He, Ellie, et al.. (2017). Safety and Effectiveness of Once-Daily Hysingla Extended-Release Tablets in Patients with Baseline Depression or Anxiety. Pain Management. 7(6). 473–488. 1 indexed citations
3.
Pergolizzi, Joseph V., Robert B. Raffa, Zachary A. Marcum, Salvatore V. Colucci, & Steven R. Ripa. (2016). Safety of buprenorphine transdermal system in the management of pain in older adults. Postgraduate Medicine. 129(1). 92–101. 12 indexed citations
4.
5.
Wen, Warren, et al.. (2015). 12-Month safety and effectiveness of once-daily hydrocodone. Journal of Opioid Management. 11(4). 339–356. 18 indexed citations
6.
7.
8.
Yarlas, Aaron, K. Miller, Warren Wen, et al.. (2015). A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression. Pain Practice. 16(4). 473–485. 6 indexed citations
9.
Miller, K., Aaron Yarlas, Warren Wen, et al.. (2014). The Impact of Buprenorphine Transdermal Delivery System on Activities of Daily Living Among Patients With Chronic Low Back Pain. Clinical Journal of Pain. 30(12). 1015–1022. 10 indexed citations
10.
Yarlas, Aaron, K. Miller, Warren Wen, et al.. (2014). Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain. Postgraduate Medicine. 127(1). 38–45. 12 indexed citations
11.
Wen, Warren, et al.. (2013). Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis. Expert Opinion on Drug Safety. 12(3). 309–319. 17 indexed citations
12.
Miller, K., Aaron Yarlas, Warren Wen, et al.. (2013). Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain. Expert Opinion on Pharmacotherapy. 14(3). 269–277. 22 indexed citations
13.
Ripa, Steven R., Bill McCarberg, Catherine Munera, Warren Wen, & Craig Landau. (2012). A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. Expert Opinion on Pharmacotherapy. 13(9). 1229–1241. 11 indexed citations
14.
15.
Steiner, Deborah, Catherine Munera, M. Hale, Steven R. Ripa, & Craig Landau. (2011). Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study. Journal of Pain. 12(11). 1163–1173. 65 indexed citations
16.
17.
18.
Kivitz, Alan, et al.. (2005). Poster 154. Archives of Physical Medicine and Rehabilitation. 86(9). e32–e32. 1 indexed citations
19.
Isaacsohn, Jonathan L., William Insull, Evan A. Stein, et al.. (2001). Long-Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia. Clinical Cardiology. 24(S4). 1–9. 12 indexed citations
20.
Glasser, Stephen P., Steven R. Ripa, Robert Weiss, et al.. (1995). Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina. The Journal of Clinical Pharmacology. 35(8). 780–784. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Kuperwasser Breakdown of academic impact, for papers by Thomas Häufel Breakdown of academic impact, for papers by Robert J. Rose Breakdown of academic impact, for papers by Ilona Steigerwald Breakdown of academic impact, for papers by Craig Landau Breakdown of academic impact, for papers by Andreas Wehrfritz Breakdown of academic impact, for papers by James Wild Breakdown of academic impact, for papers by Theresa Mallick‐Searle Breakdown of academic impact, for papers by Matthias Müller Breakdown of academic impact, for papers by Kristin Moksnes
Rankless by CCL
2026